Acute myeloid leukemia. Acute myeloid leukemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Consent to enter the study Patients with recently diagnosed acute myeloid leukemia. (New cases) Patients who will undergo chemotherapy for the first time. Patients who have the same chemotherapy protocol. Patients who are fully conscious and not under airway intubation. Patients who are not in a critical health condition and listening to music is safe for them. No current smoking No drug addiction Patients who do not have respiratory and psychological diseases diagnosed by a physician. Ability to read and write Patients who are at least 18 years old.
Exclusion criteria
Exclusion criteria: Patients undergoing outpatient chemotherapy. Patients with hearing impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score of the Rhodes Nausea and Vomiting Severity Questionnaire is less than 9. The DASS-21 score for stress is less than 19. Timepoint: Before starting the intervention and then every day for 7 days. Method of measurement: Rhodes questionnaire to measure the severity and frequency of nausea and vomiting; DASS-21 questionnaire to measure stress. | — |
Secondary
| Measure | Time frame |
|---|---|
| The quality of life score of the patients is at a good level. Timepoint: Before starting the intervention; 7 days and 30 days after the start of the intervention. Method of measurement: Quality of Life Questionnaire-Core 30 (QLQ-C30). | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences